Next Article in Journal
Deep Immunoprofiling of Large-Scale Tuberculosis Dataset at Single Cell Resolution Reveals a CD81bright γδ T Cell Population Associated with Latency
Previous Article in Journal
Immunotherapy for Parkinson’s Disease and Alzheimer’s Disease: A Promising Disease-Modifying Therapy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 13
Issue 18
10.3390/cells13181528
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Mammalian Inner Ear-Resident Immune Cells—A Scoping Review

by
Betül Karayay
1,
Heidi Olze
1 and
Agnieszka J. Szczepek
1,2,*
1
Department of Otorhinolaryngology, Head and Neck Surgery, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany
2
Faculty of Medicine and Health Sciences, University of Zielona Góra, 65-046 Zielona Góra, Poland
*
Author to whom correspondence should be addressed.
Cells 2024, 13(18), 1528; https://doi.org/10.3390/cells13181528
Submission received: 18 August 2024 / Revised: 9 September 2024 / Accepted: 10 September 2024 / Published: 12 September 2024
(This article belongs to the Section Cells of the Nervous System)
Browse Figures
Versions Notes

Abstract

:
Background: Several studies have demonstrated the presence of resident immune cells in the healthy inner ear. Aim: This scoping review aimed to systematize this knowledge by collecting the data on resident immune cells in the inner ear of different species under steady-state conditions. Methods: The databases PubMed, MEDLINE (Ovid), CINAHL (EBSCO), and LIVIVO were used to identify articles. Systematic reviews, experimental studies, and clinical data in English and German were included without time limitations. Results: The search yielded 49 eligible articles published between 1979 and 2022. Resident immune cells, including macrophages, lymphocytes, leukocytes, and mast cells, have been observed in various mammalian inner ear structures under steady-state conditions. However, the physiological function of these cells in the healthy cochlea remains unclear, providing an opportunity for basic research in inner ear biology. Conclusions: This review highlights the need for further investigation into the role of these cells, which is crucial for advancing the development of therapeutic methods for treating inner ear disorders, potentially transforming the field of otolaryngology and immunology.

1. Introduction

The inner ear is a multifaceted organ that provides the sense of hearing and balance necessary for the proper functioning of the central auditory and vestibular systems [1,2]. In addition to connecting the organism to the environment, it is also responsible for mediating social interactions [3]. The neuroanatomical and histological description of the inner ear usually focuses on its critical elements: the sensory epithelium and respective innervation [4,5], as well as cells that support the functional properties of the inner ear, such as pillar, Deiters’, Claudius’, or Hensen’s cells in the cochlea, the specialized cells of the stria vascularis producing endolymph for the entire inner ear, or the vestibular supporting cells producing otogelin and otoanchorin, both extracellular matrix proteins necessary for the proper function of the inner ear [5,6].
The term “immune-privileged tissue”, first coined in the forties of the last century and referring to the fact that such tissues do not reject a graft [7,8], has long been applied to the inner ear. This was done even though there was no precedent for tissue transplantation into the inner ear, but there was the blood–labyrinth barrier, similar to the blood–brain barrier [9]. The long-discussed existence of an inner ear lymphatic system was clarified by demonstrating rapid antigen drainage from the inner ear to the superficial ventral cervical lymph nodes of the guinea pig, as well as antigen uptake by cochlear resident macrophages and fibrocytes [10]. Over time, the presence of immune cells or immune mediators in the inner ear has been linked to pathological conditions, including infections caused by pathogens [11] or inflammation due to factors such aging [12] or drug exposure [13]. The initial electron microscopy studies have demonstrated the existence of macrophages within the cochlea of noise-exposed guinea pigs [14]. This discovery was corroborated by additional reports of infiltrating and resident macrophages in the cochlea and a modest resident population of CD45+ cells in the inferior region of the spiral ligament and spiral wall [15]. Furthermore, observations have been made regarding the increased expression of immune mediators, including cytokines, chemokines, and cell adhesion molecules, which have been shown to result in an influx of immune cells into the inner ear. Accordingly, it has been postulated that cells of hematopoietic origin and the mediators they produce may play a pivotal role in the damage to hair cells or neurons, ultimately resulting in hearing loss [15,16].
Compared to the cell biology, biophysics, and genetics of the inner ear, the immunology of the inner ear has been the subject of relatively limited investigation and warrants further study in this area. Our interest was to define the cellular component of the immune system residing in the inner ear under normal physiological conditions. Therefore, we undertook a comprehensive review of the existing evidence to advance our understanding of this area of research. We used a scoping review methodology to delineate the evidence for resident immune cells in the inner ear of different species under steady-state conditions. In addition, we aimed to summarize the cell types that have been the focus of these studies and to identify gaps in the existing literature. Therefore, the primary objectives were to identify the types of immune cells present in the mammalian inner ear under steady-state conditions and to determine the distribution of these cells across species. Consequently, the goal was to gain new knowledge that may facilitate the development of advanced therapeutics for inner ear disorders.

2. Materials and Methods

2.1. Protocol

To draft our protocol and scoping review, we followed the described methodology by Arksey and O’Malley [17] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines for scoping reviews [18]. The research team revised the protocol. The final version of the detailed protocol is accessible in Supplementary File S1. A detailed search strategy for all databases used is documented in Supplementary File S2. When the study was first drafted in 2019, and before the search was conducted, we attempted to register it in PROSPERO; however, due to the scoping nature of this review, such registration was not possible.

2.2. Information Sources and Search Strategy

A systematic search was performed in electronic databases, including PubMed, MEDLINE (Ovid), CINAHL (EBSCO), and LIVIVO. The authors designed the search strategy collaboratively, with B.K. taking the lead. The first author (B.K.) initially performed the search on 23 April 2020. The search was repeated on 22 August 2023, to avoid missing articles published after the search date. Matching search terms were used for each database, including free text words, MeSH terms, and Boolean operators. Detailed information about each database, search dates, restrictions or filters applied, number of records retrieved (for each database), and search terms for each electronic database were recorded. The search was limited by language (English and German) but not by year or study design. The reference lists of included articles were screened for missing studies that were relevant but not included in our search. A comprehensive search was conducted to minimize the possibility of missing studies that may be relevant to our research objectives. The final search strategy for all electronic databases is presented in Supplementary File S2.

2.3. Study Selection Process

Study selection consisted of two steps: first, screening of article titles and abstracts, and second, screening of full texts. Articles identified by our search strategy were exported to EndNote 21.2, and the first author removed duplicates.
The authors developed the inclusion and exclusion criteria (Table 1) applied throughout the selection procedure.
These criteria were used in both the first and second stages of screening. To determine eligibility for inclusion according to the agreed inclusion and exclusion criteria, the titles and abstracts of the articles were screened using the web-based software “Rayyan” (https://rayyan.ai/, last time accessed on 1 August 2023). The authors screened all titles and abstracts for inclusion and exclusion criteria (B.K., A.J.S.). H.O. confirmed the selection of articles. The reviewers then analyzed the full texts and assessed the inclusion criteria. The main reasons for the exclusion of an article were documented. The approach used to select studies that met the objectives of this scoping review is shown in Figure 1.

3. Results

3.1. Selection Process

The preliminary search yielded 1217 studies, of which 136 were deemed suitable for full-text screening. A total of 89 articles were excluded from further consideration due to the following reasons: 68 articles were deemed to have an inappropriate study design, 7 articles were excluded because they did not align with the specified population, 7 articles were excluded because they did not meet the criteria for the specified publication type, and 7 articles were excluded because they were background articles. A subsequent iteration of the search strategy yielded two additional articles, which were then included. Ultimately, 49 publications were deemed suitable for inclusion in the review.

3.2. Characteristics of the Studies

Forty-nine articles were published between 1980 and 2022, with 38% published between 2015 and 2020 (Table 2). Most studies were conducted in North America (46%) and Europe (34%). Immunofluorescence was the primary method of data collection (53%). Most of the studies were published by researchers associated with the departments of otolaryngology (65%) at various institutions.

3.3. Type and Distribution of Immune Cells in Rodent Ear

Twenty-five studies were dedicated to analyzing the inner ear of mice (Table 3), whereas five studies inspected the inner ear of guinea pigs (Table 4). Additionally, four studies examined the inner ear of rats and other species (Table 5). Together, these studies proved that the healthy, intact inner ear contains a population of resident macrophages (Table 3, Table 4 and Table 5).
Takahashi et al. (1988) demonstrated that the murine cochlea and the endolymphatic sac (ES) harbor macrophages [19]. In the guinea pig cochlea, macrophages were found in the lumen and perisaccular region of the ES [20]. Lang et al. (2006) provided evidence of hematopoietic cells’ ability to enter the cochlea and remain in both the modiolus and spiral ligament [21].
Various surface markers characteristic of monocytes and macrophages (Appendix A) have been used in animal studies and have shown that cochlear macrophages express Iba1, F4/80, CD68, CD163, and CX3CR1 on their surface (Table 3, Table 4 and Table 5). Iba1 (ionized calcium-binding adapter molecule 1) is a calcium-binding protein involved in macrophage activation, phagocytosis, and motility [22,23]. Okano et al. (2008) transplanted hematopoietic stem cells expressing green fluorescent protein (EGFP) into previously irradiated C57BL/6 mice [24]. Six months after transplantation, EGFP-positive cells were observed in the inner ear, most expressing Iba1 on their surface. The Iba1+ cells were observed in the spiral ligament, close to the spiral ganglia, and proximal to the basilar and Reissner’s membranes. Wakabayashi et al. (2010) demonstrated the presence of Iba1+ cells in the murine cochlea’s apical, medial, and basal turn [25].
Another well-characterized rodent macrophage marker expressed at high densities on the surface of mature macrophages is the cell surface protein F4/80 [26,27]. In addition to Iba1+ cells, F4/80 expressing cells were also observed in the spiral ligament and spiral ganglion [24]. The fractalkine receptor (CX3CR1) is a transmembrane glycoprotein and chemokine involved in the adhesion and migration of immune cells [15]. Few resident CX3CR1+ macrophages were observed in the osseous part of the spiral lamina [28].
The leukocyte common antigen (LCA), also known as cluster of differentiation-45 antigen (CD45), is a membrane-bound glycoprotein with tyrosine phosphatase activity that is expressed by all leukocytes [29]. The CD45+ cells were found in the spiral ligament, scala tympani, and spiral lamina, near the spiral ganglion cells, and under the basilar membrane (Table 3, Table 4 and Table 5). CD45+ cells were also observed to be present in the spiral limbus, the scala tympani, and the scala vestibuli, and their number increased significantly after acoustic overstimulation. Supporting these observations, CD45+ cells were reported to be distributed along the entire length of the basilar membrane [30].
Three studies have identified the presence of mast cells in rodents’ inner ears, specifically in the modiolus, spiral limbus, and ES [30]. To visualize the mast cells, the glycoprotein avidin, which has a high affinity for heparin in the mast cell granule, was employed as a staining agent, as this method has been established for use with mast cell granules [31].
Table 3. Types and distribution of immune cells in the inner ear of the mouse.
Table 3. Types and distribution of immune cells in the inner ear of the mouse.
Number of Specimens AnalyzedIdentified Immune Cell(s)Antibodies Used for IdentificationImmune Cell DistributionQuantificationRefs.
4–5MacrophagesIL-1b, Arg1, F4/80 lateral wall, OC, spiral ganglion, cochlear nerve, -[32]
3–7MacrophagesIba1, CD11b, CD68, F4/80osseous spiral lamina, Rosenthal’s canal, lateral wall-[33]
-MacrophagesCD45, F4/80, Iba1, Ly6Cbasilar membrane, OC, spiral ligament, spiral limbus, neural region in the osseous spiral lamina, ganglion neurons and modiolus. CD45+ cells: scala tympani side of mesothelial cells, OC, along the spiral vessels, spiral ligament, spiral limbus, neural regions of the cochleaCD45+ cells: average number of cells per 1 mm length of the basilar membrane decreased from 35.4 ± 6.4 during the P1–4 to 26.2 ± 6.5 at P10 and to 16.8 ± 2.4 during P17–21;
CD45+ cells in the apical region: 31.9 ± 11.7;
CD45-positive cells in the middle region: 24.1 ± 8.2;
CD45+ cells basal: 58.3 ± 2.7;
spiral limbus: 51.3 ± 3.2 cells/0.1 mm2 at P4 to 23.8 ± 3.2 at P10 and to 15.6 ± 1.3 at P17;
spiral ganglion region: 41.7 ± 3.2 cells per 0.1 mm2 at age P4, 35.3 ± 3.3 at age P10, 27.3 ± 1.2 at P17,		[34]
-MacrophagesCD45, F4/80across the entire length of the sensory epitheliumaverage number of macrophages increased from 25 ± 6 at the age of 1 month to 29 ± 3 at the age of 3–5 months and 30 ± 6 at the age of 10–12 months.
basal section: average number of macrophages was reduced from 49 ± 15 for the young group to 43 ± 11 for intermediate-aged group, and further down to 22 ± 8 for the 10–12-month group		[35]
5MacrophagesCD45, Iba1, Ly6Cspiral lamina, basilar membrane, scala tympani, osseous spiral lamina, among the peripheral
nerve bundles of ganglion neurons		spiral lamina: 30 ± 5
basal membrane: 114 ± 11		[36]
-Macrophages-in the lumen of the ES-[37]
8Immune cellsMHC class IIlateral wall, OC, modiolus, spiral ganglion-[38]
13MacrophagesBrdU, CD68, CD3, CD45spiral ligament, stria vascularis5–7 inflammatory cells per 30 μm section[15]
5MacrophagesGFPOC -[39]
4MacrophagesGFPsensory epithelium of utricles1.4 ± 0.6 macrophages/100,000 μm2 [40]
-MacrophagesIba1, CD11b, F4/80, CD68IBA1-positive macrophages: spiral ganglion, spiral ligament, stria vascularis, intraluminal surface of perilymphatic spaceIBA1-positive macrophages: 105 ± 50.8 at P0, 411 ± 36.6 at P3, 492 ± 49.9 at P6, and 513 ± 17.8 at P21 in the spiral ganglion (/mm2, mean ± SEM); 628 ± 61.9 at P0, 666 ± 47.3 at P3, 438 ± 58.8 at P6, and 270 ± 37.3 at P21 in the spiral ligament; and 0 ± 0 at P0, 430 ± 41.5 at P3, 583 ± 96 at P6, and 356 ± 32 in the stria vascularis[41]
10Leukocytes (Monocytes, Lymphocytes, Neutrophils)CD45, CD54scala vestibuli, scala media, scala tympani, spiral ligament, stria vascularis, modiolus, and limbusonly a few labeled cells[42]
-Perivascular resident macrophage-like melanocyteF4/80capillaries of the stria vascularis at the apical, middle, and basal turns1-month-old animals: 352 ± 39/mm2 stria area
21 months: 247 ± 35/mm2 stria area		[43]
12MacrophagesIba1spiral ganglion, spiral ligament, stria vascularis spiral ganglion: 3.42 ± 0.29,
spiral ligament: 4.35 ± 0.36,
stria vascularis: 6.83 ± 0.69		[44]
5MacrophagesCD45, Iba1, CD68, F4/80spiral ganglion, spiral ligament-[24]
40Perivascular resident macrophagesF4/80, CD68, CD11b, MOMA2along capillaries of the blood–labyrinth
barrier in the stria vascularis 		-[45]
40Perivascular resident macrophagesF4/80between marginal and basal layers of stria vascularis-[46]
5Mac-1-, Lyt-1-, and Lyt-2-positive cells and Immunoglobulin-positive cellsMac-1, Lyt-1, Lyt-2, immunoglobulins classes M, G and Acochlea: no positive cells found; ES: Lyt-1+ and IgM+ cell in perisaccular region, Mac-1 and IgG-positive cells in the ES region-[19]
-T cells, B cells (IgM-, IgG- and IgA-positive), MacrophagesThy-1, Lyt-1, Lyt-2, immunoglobulins classes M, G and AThy-1’ cells: throughout the ES
Lyt-l+ cells: throughout the ES
Mac-1’ cells: lumen ES
IgM+ cells: subepithelial region
IgG’ cells: lumen and perisaccular space		-[47]
6LymphocyteCD4, CD8a,ES-[48]
4MacrophagesCD45, F4/80, MHCII and Tlr4lateral wall, basilar membrane, scala tympani ~1 cell/100 µm[49]
3MacrophagesCD45, Iba1spiral ganglion, spiral ligamentless than one cell per 10,000 µm2[25]
7MacrophagesCD4, CD11c, CD14, CD45, CIITA,
F4/80 and MHCII		basilar membrane95.4 ± 16.9[30]
5Perivascular resident macrophage-like melanocytesF4/80, GSTα4semicircular
canal ampullae, utricle, saccule, and semicircular canal		utricle: 225 ± 43/mm2; saccule 191 ± 25/mm2; horizontal ampullae 212 ± 36/mm2; anterior ampullae 238 ± 36/mm2; and posterior ampullae 223 ± 64/mm2[50]
8Macrophages-spiral ligaments, stria vascularis, Reissner’s membrane-[51]
Table 4. Type and distribution of the immune cells in the inner ear of the guinea pig.
Table 4. Type and distribution of the immune cells in the inner ear of the guinea pig.
Number of Specimens AnalyzedIdentified Immune Cell(s)Immune Cell DistributionQuantificationRefs.
22LeukocytesAround the vein.-[52]
5Mast cellsSurrounding capillaries in the subepithelial connective tissue of the ES, but not detected in the stria vascularis.
Connective tissue of the ES
but not in other parts of
the inner ear.		-[53]
-Lymphoid cells, Macrophages, Lymphocytes, Plasma cells, Mast cellsES.-[54]
-Macrophages, Lymphocytes, Plasma cells, Mast cellsPerisaccular blood vessels, ES.-[55]
-
(Guinea pigs, humans)		Mast cellsIn the subepithelial connective tissue of the ES. In no other part of the inner ear.500–700 per sac, average of 605[56]
All studies used eosin–hematoxylin staining to identify the cells.
Table 5. Types and distribution of immune cells in the inner ear of the rat and monkey.
Table 5. Types and distribution of immune cells in the inner ear of the rat and monkey.
Number of Specimens AnalyzedIdentified Immune Cell(s)Antibodies Used for IdentificationImmune Cell DistributionQuantificationRefs.
18
(rats)		Leukocytes, MacrophagesCD45, ED1, CD68spiral ganglion, OC-[57]
-
(rats)		Macrophages/MicrogliaIba1cochlear aqueduct, stria vascularis, spiral ligament, endolympathic duct-[58]
-
(rats, mice)		Mast cellsc-Kit/CD117, MC chymase, MC tryptasemodiolus, the spiral limbus of both species, Reissner’s, no MCs were detected in or close to the OCWistar rats: P1 average 17 ± 12.3, P3 average 14.7 ± 8.6, P5 average 9.8 ± 6.2, P7 average 4.7 ± 3.5, and P9 average 2.6 ± 2.1[59]
6
(monkeys)		Macrophages, Plasma cells, Lymphocytes-the rim of the round window membrane-[60]

3.4. The Type and Distribution of Immune Cells in the Human Inner Ear

Sixteen of the included studies analyzed the human inner ear. The specimens utilized in human research were collected from patients undergoing surgical removal of the cochlea due to meningioma or other diseases that did not affect the cochlea, as well as from deceased individuals without a known history of hearing or balance disorders. In two instances, post-mortem temporal bones of patients who had undergone unilateral cochlear implantation were examined, with the inclusion of specimens from the non-implanted ear [61,62]. The data obtained from the latter were incorporated into the present study. In the included studies, the immunohistochemical stainings were performed with the antibodies against CD163, Iba1, and CD68 (see Table 6 and Appendix A). The CD163 protein, expressed exclusively by monocytes and macrophages, acts as a scavenger receptor [63]. CD163+ cells were located in various areas in the human inner ear, including the spiral ligament, adjacent to the basilar and Reissner’s membranes, in the spiral lamina and spiral limbus, along the blood vessels, close to the spiral ganglion neurons, in the vestibular organ, and in the ES. CD68, similarly to CD168, is a scavenger receptor exclusively expressed by monocytes and macrophages and belongs to the group of lysosomal/endosomal-associated membrane glycoproteins [63]. CD68+ cells have been identified in the human inner ear, located near the basilar and Reissner’s membranes near spiral ganglion neurons and the ES. Iba1+ cells were detected in various regions of the inner ear, including the spiral ligament, in proximity to the basilar and Reissner’s membranes, in the spiral lamina and limbus, alongside blood vessels, in the vestibular organ, proximal to spiral ganglion neurons, and in the ES. This distribution pattern is consistent with that of CD163 and CD68. Notably, macrophages in the human inner ear exhibit more significant expression of Iba1 than CD163 and CD68. Furthermore, Iba1+ macrophages were detected within the lumen of the perisaccular blood vessels of subepithelial tissue and the proximal section of the ES [54,63,64].
Additionally, immunohistochemical investigations illustrated the presence of lymphocytes (T, B, and Langerhans cells), leukocytes, and mast cells in the ESs of human inner ears (Table 6).

3.5. Summary of Immune Cell Types and Distribution across Species

Several studies have shown that immune cells have been detected at several sites in the mammalian inner ear (Table 3, Table 4, Table 5 and Table 6, Figure 2). Macrophages were observed in the ES, stria vascularis, spiral ganglion, spiral ligament, scala tympani, scala vestibuli, OC, and spiral lamina. Leukocytes and lymphocytes were found in the ES, spiral ligament, and lateral portion of the cochlea. Mast cells were observed in the ES, modiolus, and spiral ligament.

4. Discussion

This scoping review assesses the current literature on the types and distribution of immune cells in the mammalian inner ear under steady-state conditions, with a particular focus on control, experimentally unmanipulated animals. The identification of immune system cells was based on the expression of different surface molecules, including CD45, CD4, CD8, F4/80, Iba1, CD68, and CD163. Immunocytes were observed in various structures within the inner ear, as detailed in Table 6 and Figure 3. The findings suggest that innate and acquired immune cells are integral components of the mammalian inner ear under normal physiological conditions. Further research in inner ear biology is needed to understand the functions of the resident immune cells, which is of utmost importance and should be a priority for the scientific community.
In support of these observations, Jean et al. recently published the results of single-cell transcriptomics performed on mouse cochleae obtained from animals at postnatal days 8, 12, and 20 [75]. According to these data, various innate and adaptive immune cells (neutrophils, B cells, T cells, NK cells, monocytes, macrophages, and mast cells) are present in the cochlea. However, due to the methodology used, it is unclear which cells are located in the solid cochlear tissue and which are located in the cochlear blood vessels (which were not separated from the rest of the cochlear tissue during preparation). However, the presence of macrophages, which, unlike monocytes, do not circulate in the blood [76], suggests that tissue-resident immune cells were also included in this analysis.
It has been documented that resident leukocytes can be found in several human and animal body tissues. They maintain local homeostasis, patrol tissues searching for pathogens or toxins, repair potential cell damage, and remove dead or damaged cells [76,77,78]. Notably, while they retain the typical properties of a particular type of immune cell, they also possess specific characteristics unique to the particular tissue in which they reside. To illustrate, resident lung macrophages play a role in maintaining pulmonary homeostasis through surfactant uptake [79]. Furthermore, they inhibit the initiation of inflammatory responses to innocuous particulate matter [80]. The resident cardiac macrophages, originating from the yolk sac and fetal liver progenitors, express a range of growth factors and matrix metalloproteinases that facilitate cardiac tissue remodeling. Moreover, macrophages in the atrioventricular node are involved in myocyte repolarization and electrical conduction [81]. The homeostatic function of other immunocytes has yet to be the subject of extensive investigation, representing a significant avenue for further research in inner ear biology.
The particular contributions of resident immune cells to inner ear homeostasis can be elucidated by analyzing auditory function in mutants. Unfortunately, only a limited number of such analyses have been conducted. One such work demonstrates that SCID mice, which have a mutation in the Prkdc (scid) gene responsible for double-stranded DNA repair and, thus, do not produce functional T and B cells, have normal hearing abilities [82]. Interestingly, the same study showed that transferring bone marrow cells purged from T cells from MRL/Mp-lpr/lpr mice known to have systemic autoimmunity associated with systemic lupus erythematosus to SCID animals increased hearing thresholds, suggesting the detrimental role of B cells in that process. The hearing abilities of NUDE mice, which do not develop T cells, Rag1 mice, which lack T and B cells, and other immunodeficient animal models remain unknown. Further interdisciplinary research following the principles of the 3Rs and 4Rs of research would be required to gain a deeper understanding of the subject matter.
An alternative approach to gaining information about the resident immune cells is to observe otologic pathologies in patients with immunodeficiencies to elucidate the specific contributions of distinct immune system cell types to inner ear pathologies. Clinical evidence supports the association between primary immunoglobulin immunodeficiencies and hearing loss [83,84]. However, the etiology of hearing loss appears to be mixed in these disorders and often involves infections of the middle ear. The prevalence of hearing loss in persons with secondary immunodeficiencies, such as those infected with HIV or AIDS, is relatively high. A review paper analyzing hearing loss in HIV-infected children estimated it to be between 6% and 84% based on the data analyzed [85], with conductive hearing loss occurring more often than sensorineural or mixed hearing loss. The authors explain the wide range of results by the heterogeneity of the sampling and the audiometric methods used. A study by van der Westhuizen and colleagues (2013) found that among adults living with HIV, the prevalence of hearing impairment was 27.5%, tinnitus was 26%, and dizziness was 25% [86]. Again, mixed etiologies, including antiviral medicine ototoxicity, have been proposed to explain the otologic symptoms. Still, one cannot exclude the possibility that a virus-depleted number of CD4+ cells contributes to the phenotype. A study by Iwai et al. (2021) demonstrated a correlation between a declining fraction of circulating CD4+ lymphocytes and accelerated age-related hearing loss in mice [87]. The authors attributed the effect to the systemic impact of CD4+ depletion and did not observe the presence of mononuclear cells in the cochleae. Nevertheless, as these cells are usually present in small numbers, they were not detected by the hematoxylin and eosin staining used in that paper.
At present, the population of resident immune cells with the most significant amount of comprehensive understanding is that of macrophages. Nevertheless, the current evidence regarding the impact of resident macrophages on inner ear structures remains inconclusive. On the one hand, resident macrophages positively influence hair cell loss rates, tissue repair, and removal of cellular debris [28,88]. Notably, the development of ribbon synapses during the onset of hearing requires resident macrophages [89]. Additionally, macrophages are required to repair noise-damaged inner hair cell synapses [90]. On the other hand, the ability of macrophages to produce cytotoxic substances such as reactive oxygen species (ROS) and to initiate inflammatory responses after acoustic trauma suggests their potential contribution to hair cell loss [15]. The properties of resident cochlear macrophages were recently summarized in a review by Hough et al. [91]. The authors concluded that macrophages contribute to cochlear homeostasis under normal physiological conditions. However, in some cases, they can be primed and activated, which might lead to cochlear damage, resulting in hearing loss.
The pathologies of the inner ear with the potential involvement of the resident immune cells include autoimmune inner ear disease (AIED) and noise-induced hearing loss. Treating AIED and noise-induced hearing loss necessitates targeting the inflammatory response and proinflammatory cytokines [92]. McCabe et al. (1979) demonstrated that the administration of glucocorticoids to patients with AIED resulted in an improvement in hearing loss [93]. Corticosteroids remain a mainstay of first-line therapy for AIED [94]. Furthermore, clinical trials have shown that corticosteroids, including dexamethasone and methylprednisolone, effectively prevent noise-induced hearing loss [92]. Inhibition of inflammatory mediators, such as tumor necrosis factor-α (TNF-α) or interleukin-1 (IL-1), represents another potential treatment strategy for AIED. For example, a clinical study demonstrated the efficacy of the TNF-α inhibitor infliximab when administered intratympanically in treating hearing loss in patients with AIED [95,96]. However, a review of the efficacy of anti-inflammatory biologics used to treat off-label AIED revealed inconsistencies in the clinical outcomes. These inconsistencies were attributed to sample size and composition variations, biologics, and other drugs applied simultaneously. This highlights the necessity for more rigorous studies to gain a deeper understanding of the efficacy of these biologics in treating off-label AIED [97].

4.1. Limitations

The analyzed studies exhibited notable heterogeneity. Variation was observed not only in methodology but also in test samples. In some studies, the number of immune cells was not determined, but their presence was noted. It is also important to note that some relevant studies may have been overlooked despite a comprehensive search strategy.

4.2. Future Directions and Conclusions

In mammals, the inner ear contains a resident population of immune cells that maintain a steady state under normal conditions. The precise manner in which the resident immune cells contribute to inner ear homeostasis and their potential role in the pathogenesis of inner ear diseases remains unresolved and requires further investigation. Moreover, the function of the resident immune cells within the inner ear remains unclear. A more detailed and systematic examination of the spiral ligament, stria vascularis, and the modiolar spiral vein in the context of immune cells may facilitate a comprehensive understanding of inner ear immunophysiology and pathology and develop innovative therapeutic interventions. Furthermore, no study distinguished between resident and infiltrated immune cell populations using the same tissue sample, which presents an intriguing opportunity for further investigation. This fascinating interdisciplinary field necessitates close collaboration between otologists, inner ear biologists, and immunologists.

5. Conclusions

This review examines the current knowledge regarding resident immune cells in the inner ear of various mammalian species. A comprehensive analysis of the findings revealed the presence of resident immune cells in the inner ear of all organisms studied under normal physiological conditions. The knowledge in this review may facilitate future research into the physiology and diseases of the inner ear. However, further research is needed to clarify the role of resident immune cells in the inner ear.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/cells13181528/s1, File S1: protocol; File S2: search strategy. References [1,2,9,14,15,16,29,46,57,98,99,100,101,102] are cited in the supplementary materials.

Author Contributions

Conceptualization, B.K. and A.J.S.; methodology, B.K. and A.J.S.; validation, B.K. and A.J.S.; formal analysis, B.K.; investigation, B.K. and A.J.S.; resources, A.J.S. and H.O.; data curation, B.K. and A.J.S.; writing, B.K.; writing—review and editing, B.K., H.O. and A.J.S.; supervision, A.J.S. and H.O.; project administration, A.J.S.; funding acquisition, A.J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created in this work.

Conflicts of Interest

The authors declare no conflicts of interest.

Appendix A

Table A1. A comprehensive list of the immune markers employed in the publications included in this review. The table also includes the alternative names of the molecules, their ligands, and their principal functions. The data regarding the cell type in which the markers are expressed (T cells, B cells, NK cells, macrophages, granulocytes, and mast cells) pertain to humans and mice.
Table A1. A comprehensive list of the immune markers employed in the publications included in this review. The table also includes the alternative names of the molecules, their ligands, and their principal functions. The data regarding the cell type in which the markers are expressed (T cells, B cells, NK cells, macrophages, granulocytes, and mast cells) pertain to humans and mice.
MarkerAlternative NameLigandT CellB CellNK CellMacrophage/MonocyteGranulocyteMast CellFunctionReferences
CD1Leu6Lipids and glycolipids + + Lipid and glycolipid antigen presentation.[103]
CD3Leu4TCR complex+ + Signal transduction[103]
CD4L3T4, Leu3aMHC class II, IL-16, receptor for HIV+ ++ Signal transduction, receptor/coreceptor.[103]
CD5Lyt-1CD72++ Adhesion, regulation of T–B lymphocyte interaction.[103]
CD6T12CD166+ Activation/costimulation, adhesion, differentiation/development.[103]
CD8Leu2, Lyt-2MHC class I+ Signal transduction, receptor/coreceptor for MHC class I molecules.[103]
CD117c-KITStem cell factor (c-kit ligand) +Pivotal role in the proliferation and differentiation of various cell types. Indispensable for maintaining hematopoietic stem cells in the bone marrow and mast cells’ development and function.[103]
CD11bIntegrin αM, Ly-40CD54, fibronectin+++++ Adhesion, chemotaxis, apoptosis.[103]
CD14LPS ReceptorLPS ++ Pathogen recognition, inflammation.[103]
CD22SIGLEC-2Sialic acid + B cell adhesion, immunoregulation, receptor/coreceptor, signal transduction.[103]
CD45Leukocyte common antigen (LCA)CD150, galectin-1, CD2, CD3, CD4++++++T and B cell antigen receptor signaling, regulator of cell growth
and differentiation.		[103]
CD54ICAM-1, Ly-47 ++ + +Cell adhesion, lymphocyte activation and migration.[103]
CD68LAMP4Low-density lipoprotein, phosphatidylserine, apoptotic cells + Phagocytosis.[103,104]
CD90Thy-1Not yet identified+ ++ Signal transduction, activation/costimulation, adhesion, differentiation/development.[103]
CD163SCARI1Hemoglobin–haptoglobin complex + Scavenger receptor.[105]
CD284Toll-like receptor 4 (TLR4)Lipopolysaccharide (LPS), high mobility group box 1 (HMGB1), heat shock proteins++++++Recognition of damage or pathogen-associated molecular patterns.[106,107,108,109]
CX3CR1Fractalkine receptor or G-protein coupled receptor 13Neurotactin/fractalkine++++++Cell adhesion, migration, survival, proliferation, neuroprotection.[110,111]
F4/80EGF-like module-containing mucin-like hormone receptor-like 1Not yet identified ++ immune response modulation and inflammation.[112]
Iba1Allograft inflammatory factor 1 (AIF-1)Fimbrin + Membrane ruffling and phagocytosis.[113,114]
Mac-1Complement receptor 3ICAM1, ICAM2+++++ Phagocytosis, pattern recognition receptor.[103]

References

  1. Cope, T.E.; Baguley, D.M.; Griffiths, T.D. The functional anatomy of central auditory processing. Pract. Neurol. 2015, 15, 302–308. [Google Scholar] [CrossRef] [PubMed]
  2. Fettiplace, R.; Kim, K.X. The physiology of mechanoelectrical transduction channels in hearing. Physiol. Rev. 2014, 94, 951–986. [Google Scholar] [CrossRef] [PubMed]
  3. Morgan, G.; Curtin, M.; Botting, N. The interplay between early social interaction, language and executive function development in deaf and hearing infants. Infant. Behav. Dev. 2021, 64, 101591. [Google Scholar] [CrossRef]
  4. Khan, S.; Chang, R. Anatomy of the vestibular system: A review. NeuroRehabilitation 2013, 32, 437–443. [Google Scholar] [CrossRef]
  5. Raphael, Y.; Altschuler, R.A. Structure and innervation of the cochlea. Brain Res. Bull. 2003, 60, 397–422. [Google Scholar] [CrossRef]
  6. Wan, G.; Corfas, G.; Stone, J.S. Inner ear supporting cells: Rethinking the silent majority. Semin. Cell Dev. Biol. 2013, 24, 448–459. [Google Scholar] [CrossRef]
  7. Barker, C.F.; Billingham, R.E. Immunologically privileged sites. Adv. Immunol. 1977, 25, 1–54. [Google Scholar]
  8. Habel, K.; Belcher, J.H. Immunologically privileged sites in studies of polyoma tumor antigens. Proc. Soc. Exp. Biol. Med. 1963, 113, 148–152. [Google Scholar] [CrossRef] [PubMed]
  9. Harris, J.P. Immunology of the inner ear: Response of the inner ear to antigen challenge. Otolaryngol. Head Neck Surg. 1983, 91, 18–23. [Google Scholar] [CrossRef] [PubMed]
  10. Yimtae, K.; Song, H.; Billings, P.; Harris, J.P.; Keithley, E.M. Connection Between the Inner Ear and the Lymphatic System. Laryngoscope 2001, 111, 1631–1635. [Google Scholar] [CrossRef]
  11. Capra, D.; DosSantos, M.F.; Sanz, C.K.; Acosta Filha, L.G.; Nunes, P.; Heringer, M.; Ximenes-da-Silva, A.; Pessoa, L.; de Mattos Coelho-Aguiar, J.; da Fonseca, A.C.C.; et al. Pathophysiology and mechanisms of hearing impairment related to neonatal infection diseases. Front. Microbiol. 2023, 14, 1162554. [Google Scholar] [CrossRef]
  12. Watson, N.; Ding, B.; Zhu, X.; Frisina, R.D. Chronic inflammation—Inflammaging—In the ageing cochlea: A novel target for future presbycusis therapy. Ageing Res. Rev. 2017, 40, 142–148. [Google Scholar] [CrossRef] [PubMed]
  13. Ramkumar, V.; Mukherjea, D.; Dhukhwa, A.; Rybak, L.P. Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity. Antioxidants 2021, 10, 1919. [Google Scholar] [CrossRef]
  14. Fredelius, L.; Rask-Andersen, H. The role of macrophages in the disposal of degeneration products within the organ of corti after acoustic overstimulation. Acta Oto-Laryngol. 1990, 109, 76–82. [Google Scholar] [CrossRef]
  15. Hirose, K.; Discolo, C.M.; Keasler, J.R.; Ransohoff, R. Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma. J. Comp. Neurol. 2005, 489, 180–194. [Google Scholar] [CrossRef]
  16. Tornabene, S.V.; Sato, K.; Pham, L.; Billings, P.; Keithley, E.M. Immune cell recruitment following acoustic trauma. Hear. Res. 2006, 222, 115–124. [Google Scholar] [CrossRef]
  17. Arksey, H.; O’Malley, L. Scoping studies: Towards a methodological framework. Int. J. Soc. Res. Methodol. 2005, 8, 19–32. [Google Scholar] [CrossRef]
  18. Tricco, A.C.; Lillie, E.; Zarin, W.; O’Brien, K.K.; Colquhoun, H.; Levac, D.; Moher, D.; Peters, M.D.J.; Horsley, T.; Weeks, L.; et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann. Intern. Med. 2018, 169, 467–473. [Google Scholar] [CrossRef]
  19. Takahashi, M.; Harris, J.P. Analysis of immunocompetent cells following inner ear immunostimulation. Laryngoscope 1988, 98, 1133–1138. [Google Scholar] [CrossRef] [PubMed]
  20. Tomiyama, S.; Harris, J.P. The endolymphatic sac: Its importance in inner ear immune responses. Laryngoscope 1986, 96, 685–691. [Google Scholar] [CrossRef] [PubMed]
  21. Lang, H.; Ebihara, Y.; Schmiedt, R.A.; Minamiguchi, H.; Zhou, D.; Smythe, N.; Liu, L.; Ogawa, M.; Schulte, B.A. Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear: Mesenchymal cells and fibrocytes. J. Comp. Neurol. 2006, 496, 187–201. [Google Scholar] [CrossRef] [PubMed]
  22. Utans, U.; Arceci, R.J.; Yamashita, Y.; Russell, M.E. Cloning and characterization of allograft inflammatory factor-1: A novel macrophage factor identified in rat cardiac allografts with chronic rejection. J. Clin. Investig. 1995, 95, 2954–2962. [Google Scholar] [CrossRef] [PubMed]
  23. Sasaki, Y.; Ohsawa, K.; Kanazawa, H.; Kohsaka, S.; Imai, Y. Iba1 is an actin-cross-linking protein in macrophages/microglia. Biochem. Biophys. Res. Commun. 2001, 286, 292–297. [Google Scholar] [CrossRef]
  24. Okano, T.; Nakagawa, T.; Kita, T.; Kada, S.; Yoshimoto, M.; Nakahata, T.; Ito, J. Bone marrow-derived cells expressing Iba1 are constitutively present as resident tissue macrophages in the mouse cochlea. J. Neurosci. Res. 2008, 86, 1758–1767. [Google Scholar] [CrossRef]
  25. Wakabayashi, K.; Fujioka, M.; Kanzaki, S.; Okano, H.J.; Shibata, S.; Yamashita, D.; Masuda, M.; Mihara, M.; Ohsugi, Y.; Ogawa, K.; et al. Blockade of interleukin-6 signaling suppressed cochlear inflammatory response and improved hearing impairment in noise-damaged mice cochlea. Neurosci. Res. 2010, 66, 345–352. [Google Scholar] [CrossRef]
  26. Hirsch, S.; Austyn, J.M.; Gordon, S. Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J. Exp. Med. 1981, 154, 713–725. [Google Scholar] [CrossRef]
  27. Leenen, P.J.; de Bruijn, M.F.; Voerman, J.S.; Campbell, P.A.; van Ewijk, W. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 1994, 174, 5–19. [Google Scholar] [CrossRef] [PubMed]
  28. Kaur, T.; Zamani, D.; Tong, L.; Rubel, E.W.; Ohlemiller, K.K.; Hirose, K.; Warchol, M.E. Fractalkine Signaling Regulates Macrophage Recruitment into the Cochlea and Promotes the Survival of Spiral Ganglion Neurons after Selective Hair Cell Lesion. J. Neurosci. 2015, 35, 15050–15061. [Google Scholar] [CrossRef]
  29. Altin, J.G.; Sloan, E.K. The role of CD45 and CD45-associated molecules in T cell activation. Immunol. Cell Biol. 1997, 75, 430–445. [Google Scholar] [CrossRef]
  30. Yang, W.; Vethanayagam, R.R.; Dong, Y.; Cai, Q.; Hu, B.H. Activation of the antigen presentation function of mononuclear phagocyte populations associated with the basilar membrane of the cochlea after acoustic overstimulation. Neuroscience 2015, 303, 1–15. [Google Scholar] [CrossRef]
  31. Bergstresser, P.R.; Tigelaar, R.E.; Tharp, M.D. Conjugated avidin identifies cutaneous rodent and human mast cells. J. Investig. Dermatol. 1984, 83, 214–218. [Google Scholar] [CrossRef] [PubMed]
  32. Bas, E.; Goncalves, S.; Adams, M.; Dinh, C.T.; Bas, J.M.; Van De Water, T.R.; Eshraghi, A.A. Spiral ganglion cells and macrophages initiate neuro-inflammation and scarring following cochlear implantation. Front. Cell. Neurosci. 2015, 9, 303. [Google Scholar] [CrossRef] [PubMed]
  33. Brown, L.N.; Xing, Y.; Noble, K.V.; Barth, J.L.; Panganiban, C.H.; Smythe, N.M.; Bridges, M.C.; Zhu, J.; Lang, H. Macrophage-mediated glial cell elimination in the postnatal mouse cochlea. Front. Mol. Neurosci. 2017, 10, 407. [Google Scholar] [CrossRef]
  34. Dong, Y.; Zhang, C.; Frye, M.; Yang, W.; Ding, D.; Sharma, A.; Guo, W.; Hu, B.H. Differential fates of tissue macrophages in the cochlea during postnatal development. Hear. Res. 2018, 365, 110–126. [Google Scholar] [CrossRef]
  35. Frye, M.D.; Yang, W.; Zhang, C.; Xiong, B.; Hu, B.H. Dynamic activation of basilar membrane macrophages in response to chronic sensory cell degeneration in aging mouse cochleae. Hear. Res. 2017, 344, 125–134. [Google Scholar] [CrossRef]
  36. Frye, M.D.; Zhang, C.; Hu, B.H. Lower level noise exposure that produces only TTS modulates the immune homeostasis of cochlear macrophages. J. Neuroimmunol. 2018, 323, 152–166. [Google Scholar] [CrossRef]
  37. Furuta, H.; Mori, N.; Fujita, M.; Sakai, S. Ultrastructure of the endolymphatic sac in the mouse. Acta Anat. 1991, 141, 193–198. [Google Scholar] [CrossRef] [PubMed]
  38. Gloddek, B.; Bodmer, D.; Brors, D.; Keithley, E.M.; Ryan, A.F. Induction of MHC class II antigens on cells of the inner ear. Audiol. Neuro-Otol. 2002, 7, 317–323. [Google Scholar] [CrossRef] [PubMed]
  39. Kaur, T.; Clayman, A.C.; Nash, A.J.; Schrader, A.D.; Warchol, M.E.; Ohlemiller, K.K. Lack of fractalkine receptor on macrophages impairs spontaneous recovery of ribbon synapses after moderate noise trauma in c57bl/6 mice. Front. Neurosci. 2019, 13, 620. [Google Scholar] [CrossRef]
  40. Kaur, T.; Hirose, K.; Rubel, E.W.; Warchol, M.E. Macrophage recruitment and epithelial repair following hair cell injury in the mouse utricle. Front. Cell. Neurosci. 2015, 9, 150. [Google Scholar] [CrossRef]
  41. Kishimoto, I.; Okano, T.; Nishimura, K.; Motohashi, T.; Omori, K. Early Development of Resident Macrophages in the Mouse Cochlea Depends on Yolk Sac Hematopoiesis. Front. Neurol. 2019, 10, 1115. [Google Scholar] [CrossRef] [PubMed]
  42. Miyao, M.; Firestein, G.S.; Keithley, E.M.; Miyao, M.; Firestein, G.S.; Keithley, E.M. Acoustic trauma augments the cochlear immune response to antigen. Laryngoscope 2008, 118, 1801–1808. [Google Scholar] [CrossRef]
  43. Neng, L.; Zhang, J.; Yang, J.; Zhang, F.; Lopez, I.A.; Dong, M.; Shi, X. Structural changes in thestrial blood-labyrinth barrier of aged C57BL/6 mice. Cell Tissue Res. 2015, 361, 685–696. [Google Scholar] [CrossRef] [PubMed]
  44. Okano, T.; Kishimoto, I. Csf1 Signaling Regulates Maintenance of Resident Macrophages and Bone Formation in the Mouse Cochlea. Front. Neurol. 2019, 10, 1244. [Google Scholar] [CrossRef] [PubMed]
  45. Shi, X. Resident macrophages in the cochlear blood-labyrinth barrier and their renewal via migration of bone-marrow-derived cells. Cell Tissue Res. 2010, 342, 21–30. [Google Scholar] [CrossRef]
  46. Zhang, W.; Dai, M.; Fridberger, A.; Hassan, A.; Degagne, J.; Neng, L.; Zhang, F.; He, W.; Ren, T.; Trune, D.; et al. Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier. Proc. Natl. Acad. Sci. USA 2012, 109, 10388–10393. [Google Scholar] [CrossRef]
  47. Takahashi, M.; Harris, J.P. Anatomic distribution and localization of immunocompetent cells in normal mouse endolymphatic sac. Acta Oto-Laryngol. 1988, 106, 409–416. [Google Scholar] [CrossRef]
  48. Tomiyama, S. Th1: Mediator lymphocytes in experimental autoimmune labyrinthitis. Acta Oto-Laryngol. 2001, 121, 673–678. [Google Scholar] [CrossRef]
  49. Vethanayagam, R.R.; Yang, W.; Dong, Y.; Hu, B.H. Toll-like receptor 4 modulates the cochlear immune response to acoustic injury. Cell Death Dis. 2016, 7, e2245. [Google Scholar] [CrossRef]
  50. Zhang, F.; Zhang, J.; Neng, L.; Shi, X. Characterization and inflammatory response of perivascular-resident macrophage-like melanocytes in the vestibular system. JARO J. Assoc. Res. Otolaryngol. 2013, 14, 635–643. [Google Scholar] [CrossRef]
  51. Bae, S.H.; Kwak, S.H.; Yoo, J.E.; Kim, K.M.; Hyun, Y.M.; Choi, J.Y.; Jung, J. Three-Dimensional Distribution of Cochlear Macrophages in the Lateral Wall of Cleared Cochlea. Clin. Exp. Otorhinolaryngol. 2021, 14, 179–184. [Google Scholar] [CrossRef] [PubMed]
  52. Keithley, E.M.; Wang, X.; Barkdull, G.C. Tumor necrosis factor alpha can induce recruitment of inflammatory cells to the cochlea. Otol. Neurotol. 2008, 29, 854–859. [Google Scholar] [CrossRef] [PubMed]
  53. Miyamura, K.; Kanzaki, Y.; Nagata, M.; Ishikawa, T. Provocation of nystagmus and deviation by type I allergy in the inner ear of the guinea pig. Ann. Allergy 1987, 58, 36–40. [Google Scholar] [PubMed]
  54. Rask-Andersen, H.; Stahle, J. Lymphocyte-Macrophage Activity in the Endolymphatic Sac. ORL J. Oto-Rhino-Laryngol. Head Neck Surg. 1979, 41, 177–192. [Google Scholar] [CrossRef] [PubMed]
  55. Rask-Andersen, H.; Stahle, J. Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac. Acta Oto-Laryngol. 1980, 89, 283–294. [Google Scholar] [CrossRef]
  56. Sleeckx, J.P.; Shea, J.J.; Peremans, J.M. The mast cells of the inner ear. Acta Oto-Rhino-Laryngol. Belg. 1976, 30, 443–449. [Google Scholar]
  57. Ladrech, S.; Wang, J.; Simonneau, L.; Puel, J.L.; Lenoir, M. Macrophage contribution to the response of the rat organ of Corti to amikacin. J. Neurosci. Res. 2007, 85, 1970–1979. [Google Scholar] [CrossRef]
  58. Perin, P.; Voigt, F.F.; Bethge, P.; Helmchen, F.; Pizzala, R. iDISCO+ for the study of neuroimmune architecture of the rat auditory brainstem. Front. Neuroanat. 2019, 13, 15. [Google Scholar] [CrossRef]
  59. Szczepek, A.J.; Dudnik, T.; Karayay, B.; Sergeeva, V.; Olze, H.; Smorodchenko, A. Mast Cells in the Auditory Periphery of Rodents. Brain Sci. 2020, 10, 697. [Google Scholar] [CrossRef]
  60. Engmer, C.; Laurell, G.; Bagger-Sjoback, D.; Rask-Andersen, H. Immunodefense of the round window. Laryngoscope 2008, 118, 1057–1062. [Google Scholar] [CrossRef]
  61. Okayasu, T.; O’Malley, J.T.; Nadol, J.B. Density of Macrophages Immunostained with Anti-iba1 Antibody in the Vestibular Endorgans After Cochlear Implantation in the Human. Otol. Neurotol. Off. Publ. Am. Otol. Soc. Am. Neurotol. Soc. Eur. Acad. Otol. Neurotol. 2019, 40, e774–e781. [Google Scholar] [CrossRef] [PubMed]
  62. Okayasu, T.; Quesnel, A.M.; O’Malley, J.T.; Kamakura, T.; Nadol, J.B. The Distribution and Prevalence of Macrophages in the Cochlea Following Cochlear Implantation in the Human: An Immunohistochemical Study Using Anti-Iba1 Antibody. Otol. Neurotol. Off. Publ. Am. Otol. Soc. Am. Neurotol. Soc. Eur. Acad. Otol. Neurotol. 2020, 41, e304–e316. [Google Scholar] [CrossRef] [PubMed]
  63. O’Malley, J.T.; Nadol, J.B., Jr.; McKenna, M.J.; Nadol, J.B., Jr. Anti CD163+, Iba1+, and CD68+ Cells in the Adult Human Inner Ear: Normal Distribution of an Unappreciated Class of Macrophages/Microglia and Implications for Inflammatory Otopathology in Humans. Otol. Neurotol. 2016, 37, 99–108. [Google Scholar] [CrossRef]
  64. Wackym, P.A.; Friberg, U.; Linthicum, F.H., Jr.; Bagger-Sjoback, D.; Bui, H.T.; Hofman, F.; Rask-Andersen, H. Human endolymphatic sac: Morphologic evidence of immunologic function. Ann. Otol. Rhinol. Laryngol. 1987, 96, 276–281. [Google Scholar] [CrossRef] [PubMed]
  65. Altermatt, H.J.; Gebbers, J.O.; Muller, C.; Arnold, W.; Laissue, J.A. Human endolymphatic sac: Evidence for a role in inner ear immune defence. Orl 1990, 52, 143–148. [Google Scholar] [CrossRef]
  66. Arnold, W.; Altermatt, H.J.; Gebbers, J.O.; Laissue, J. Secretory immunoglobulin A in the human endolymphatic sac. An immunohistochemical study. ORL J. Otorhinolaryngol. Relat. Spec. 1984, 46, 286–288. [Google Scholar] [CrossRef]
  67. Borghesan, E. NATURE of a PIGMENTED SUBSTANCE in THE LABYRINTH. Acta Otolaryng 1964, 57, 288–293. [Google Scholar] [CrossRef]
  68. Liu, W.; Molnar, M.; Garnham, C.; Benav, H.; Rask-Andersen, H. Macrophages in the human cochlea: Saviors or predators—A study using super-resolution immunohistochemistry. Front. Immunol. 2018, 9, 223. [Google Scholar] [CrossRef] [PubMed]
  69. Liu, W.; Nordstrom, C.K.; Danckwardt-Lilliestrom, N.; Rask-Andersen, H. Human inner ear immune activity: A super-resolution immunohistochemistry study. Front. Neurol. 2019, 10, 728. [Google Scholar] [CrossRef]
  70. Liu, W.; Rask-Andersen, H. Super-resolution immunohistochemistry study on CD4 and CD8 cells and the relation to macrophages in human cochlea. J. Otol. 2019, 14, 1–5. [Google Scholar] [CrossRef]
  71. Noble, K.V.; Liu, T.; Matthews, L.J.; Schulte, B.A.; Lang, H. Age-related changes in immune cells of the human cochlea. Front. Neurol. 2019, 10, 895. [Google Scholar] [CrossRef] [PubMed]
  72. Nordstrom, C.K.; Danckwardt-Lilliestrom, N.; Laurell, G.; Liu, W.; Rask-Andersen, H. The human endolymphatic sac and inner ear immmunity: Marcrophage interaction and molecular expression. Front. Immunol. 2019, 10, 3181. [Google Scholar]
  73. Rask-Andersen, H.; Lilliestrom-Danckwardt, N.; Feiberg, U.; House, W. Lymphocyte-macrophage activity in the human endolymphatic sac. Acta Oto-Laryngol. Suppl. 1991, 485, 15–17. [Google Scholar] [CrossRef] [PubMed]
  74. Liu, W.; Danckwardt-Lilliestrom, N.; Schrott-Fischer, A.; Glueckert, R.; Rask-Andersen, H. Distribution of Immune Cells Including Macrophages in the Human Cochlea. Front. Neurol. 2021, 12, 781702. [Google Scholar] [CrossRef]
  75. Jean, P.; Wong Jun Tai, F.; Singh-Estivalet, A.; Lelli, A.; Scandola, C.; Megharba, S.; Schmutz, S.; Roux, S.; Mechaussier, S.; Sudres, M.; et al. Single-cell transcriptomic profiling of the mouse cochlea: An atlas for targeted therapies. Proc. Natl. Acad. Sci. USA 2023, 120, e2221744120. [Google Scholar] [CrossRef]
  76. Gray, J.I.; Farber, D.L. Tissue-Resident Immune Cells in Humans. Annu. Rev. Immunol. 2022, 40, 195–220. [Google Scholar] [CrossRef]
  77. Davies, L.C.; Jenkins, S.J.; Allen, J.E.; Taylor, P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14, 986–995. [Google Scholar] [CrossRef]
  78. Masopust, D.; Soerens, A.G. Tissue-Resident T Cells and Other Resident Leukocytes. Annu. Rev. Immunol. 2019, 37, 521–546. [Google Scholar] [CrossRef]
  79. Huang, X.; Cao, M.; Xiao, Y. Alveolar macrophages in pulmonary alveolar proteinosis: Origin, function, and therapeutic strategies. Front. Immunol. 2023, 14, 1195988. [Google Scholar] [CrossRef]
  80. Bissonnette, E.Y.; Lauzon-Joset, J.F.; Debley, J.S.; Ziegler, S.F. Cross-Talk Between Alveolar Macrophages and Lung Epithelial Cells is Essential to Maintain Lung Homeostasis. Front. Immunol. 2020, 11, 583042. [Google Scholar] [CrossRef]
  81. Ma, Y.; Mouton, A.J.; Lindsey, M.L. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl. Res. 2018, 191, 15–28. [Google Scholar] [CrossRef] [PubMed]
  82. Iwai, H.; Lee, S.; Baba, S.; Tomoda, K.; Inaba, M.; Ikehara, S.; Yamashita, T. Bone marrow cells as an origin of immune-mediated hearing loss. Acta Otolaryngol. 2004, 124, 8–12. [Google Scholar] [CrossRef]
  83. Berlucchi, M.; Soresina, A.; Redaelli De Zinis, L.O.; Valetti, L.; Valotti, R.; Lougaris, V.; Meini, A.; Salsi, D.; Nicolai, P.; Plebani, A. Sensorineural Hearing Loss in Primary Antibody Deficiency Disorders. J. Pediatr. 2008, 153, 293–296. [Google Scholar] [CrossRef] [PubMed]
  84. Eşki, E.; Usta, B.E.; Asilsoy, S.; Yılmaz, İ. Sensorineural Hearing Loss in Selective Immunglobulin A Deficiency. Turk. Arch. Otorhinolaryngol. 2017, 55, 31–33. [Google Scholar] [CrossRef] [PubMed]
  85. Dawood, G.; Klop, D.; Olivier, E.; Elliott, H.; Pillay, M.; Grimmer, K. Nature and extent of hearing loss in HIV-infected children: A scoping review. Int. J. Pediatr. Otorhinolaryngol. 2020, 134, 110036. [Google Scholar] [CrossRef] [PubMed]
  86. van der Westhuizen, Y.; Swanepoel de, W.; Heinze, B.; Hofmeyr, L.M. Auditory and otological manifestations in adults with HIV/AIDS. Int. J. Audiol. 2013, 52, 37–43. [Google Scholar] [CrossRef]
  87. Iwai, H.; Inaba, M.; Van Bui, D.; Suzuki, K.; Sakagami, T.; Yun, Y.; Mitani, A.; Kobayashi, Y.; Kanda, A. Treg and IL-1 receptor type 2-expressing CD4+ T cell-deleted CD4+ T cell fraction prevents the progression of age-related hearing loss in a mouse model. J. Neuroimmunol. 2021, 357, 577628. [Google Scholar] [CrossRef]
  88. Sato, E.; Shick, H.E.; Ransohoff, R.M.; Hirose, K. Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury. JARO J. Assoc. Res. Otolaryngol. 2010, 11, 223–234. [Google Scholar] [CrossRef]
  89. Song, X.; Li, Y.; Guo, R.; Yu, Q.; Liu, S.; Teng, Q.; Chen, Z.R.; Xie, J.; Gong, S.; Liu, K. Cochlear resident macrophage mediates development of ribbon synapses via CX3CR1/CX3CL1 axis. Front. Mol. Neurosci. 2022, 15, 1031278. [Google Scholar] [CrossRef]
  90. Manickam, V.; Gawande, D.Y.; Stothert, A.R.; Clayman, A.C.; Batalkina, L.; Warchol, M.E.; Ohlemiller, K.K.; Kaur, T. Macrophages Promote Repair of Inner Hair Cell Ribbon Synapses following Noise-Induced Cochlear Synaptopathy. J. Neurosci. 2023, 43, 2075–2089. [Google Scholar] [CrossRef]
  91. Hough, K.; Verschuur, C.A.; Cunningham, C.; Newman, T.A. Macrophages in the cochlea; an immunological link between risk factors and progressive hearing loss. Glia 2022, 70, 219–238. [Google Scholar] [CrossRef] [PubMed]
  92. Vambutas, A.; Pathak, S. AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss. Laryngoscope Investig. Otolaryngol. 2016, 1, 110–115. [Google Scholar] [CrossRef] [PubMed]
  93. McCabe, B.F. Autoimmune sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 1979, 88, 585–589. [Google Scholar] [CrossRef] [PubMed]
  94. Breslin, N.K.; Varadarajan, V.V.; Sobel, E.S.; Haberman, R.S. Autoimmune inner ear disease: A systematic review of management. Laryngoscope Investig. Otolaryngol. 2020, 5, 1217–1226. [Google Scholar] [CrossRef] [PubMed]
  95. Mata-Castro, N.; Sanz-López, L.; Varillas-Delgado, D.; García-Fernández, A. Intratympanic infliximab is a safe and effective rescue therapy for refractory immune-mediated hearing loss. Eur. Arch. Otorhinolaryngol. 2020, 277, 393–400. [Google Scholar] [CrossRef]
  96. Van Wijk, F.; Staecker, H.; Keithley, E.; Lefebvre, P.P. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol. Neurootol. 2006, 11, 357–365. [Google Scholar] [CrossRef]
  97. Balouch, B.; Meehan, R.; Suresh, A.; Zaheer, H.A.; Jabir, A.R.; Qatanani, A.M.; Suresh, V.; Kaleem, S.Z.; McKinnon, B.J. Use of biologics for treatment of autoimmune inner ear disease. Am. J. Otolaryngol. 2022, 43, 103576. [Google Scholar] [CrossRef]
  98. Klinke, R.; Pape, H.; Kurtz, A.; Silbernagl, S.; Baumann, R.; Brenner, B.; Gay, R.; Rothenburger, A. Physiologie; 6. vollständig überarb. Aufl.; Thieme: Stuttgart, Germany, 2010. [Google Scholar]
  99. Wood, M.B.; Zuo, J. The Contribution of Immune Infiltrates to Ototoxicity and Cochlear Hair Cell Loss. Front. Cell. Neurosci. 2017, 11, 106. [Google Scholar] [CrossRef]
  100. Harris, J.P. Experimental autoimmune sensorineural hearing loss. Laryngoscope 1987, 97, 63–76. [Google Scholar] [CrossRef]
  101. Harris, J.P.; Ryan, A.F. Fundamental immune mechanisms of the brain and inner ear. Otolaryngol.—Head Neck Surg. 1995, 112, 639–653. [Google Scholar] [CrossRef]
  102. Tan, W.J.; Thorne, P.R.; Vlajkovic, S.M. Characterisation of cochlear inflammation in mice following acute and chronic noise exposure. Histochem. Cell. Biol. 2016, 146, 219–230. [Google Scholar] [CrossRef] [PubMed]
  103. Abbas, A.K.; Lichtman, A.H.; Pillai, S. Cellular and Molecular Immunology E-Book: Cellular and Molecular Immunology, 10th ed.; Elsevier Health Sciences: Philadephia, PA, USA, 2022; p. 618. [Google Scholar]
  104. Chistiakov, D.A.; Killingsworth, M.C.; Myasoedova, V.A.; Orekhov, A.N.; Bobryshev, Y.V. CD68/macrosialin: Not just a histochemical marker. Lab. Investig. 2017, 97, 4–13. [Google Scholar] [CrossRef] [PubMed]
  105. Schaer, D.J.; Schaer, C.A.; Buehler, P.W.; Boykins, R.A.; Schoedon, G.; Alayash, A.I.; Schaffner, A. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 2006, 107, 373–380. [Google Scholar] [CrossRef] [PubMed]
  106. Sandig, H.; Bulfone-Paus, S. TLR signaling in mast cells: Common and unique features. Front. Immunol. 2012, 3, 185. [Google Scholar] [CrossRef]
  107. Souza-Fonseca-Guimaraes, F.; Parlato, M.; Philippart, F.; Misset, B.; Cavaillon, J.-M.; Adib-Conquy, M.; the Captain study group. Toll-like receptors expression and interferon-γ production by NK cells in human sepsis. Crit. Care 2012, 16, R206. [Google Scholar] [CrossRef]
  108. Buchta, C.M.; Bishop, G.A. Toll-like receptors and B cells: Functions and mechanisms. Immunol. Res. 2014, 59, 12–22. [Google Scholar] [CrossRef]
  109. Ciesielska, A.; Matyjek, M.; Kwiatkowska, K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell. Mol. Life Sci. 2021, 78, 1233–1261. [Google Scholar] [CrossRef]
  110. Lee, M.; Lee, Y.; Song, J.; Lee, J.; Chang, S.Y. Tissue-specific Role of CX(3)CR1 Expressing Immune Cells and Their Relationships with Human Disease. Immune Netw. 2018, 18, e5. [Google Scholar] [CrossRef]
  111. Corcione, A.; Ferretti, E.; Bertolotto, M.; Fais, F.; Raffaghello, L.; Gregorio, A.; Tenca, C.; Ottonello, L.; Gambini, C.; Furtado, G.; et al. CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes. PLoS ONE 2009, 4, e8485. [Google Scholar] [CrossRef]
  112. Hamann, J.; Aust, G.; Araç, D.; Engel, F.B.; Formstone, C.; Fredriksson, R.; Hall, R.A.; Harty, B.L.; Kirchhoff, C.; Knapp, B.; et al. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. Pharmacol. Rev. 2015, 67, 338–367. [Google Scholar] [CrossRef]
  113. Ohsawa, K.; Imai, Y.; Sasaki, Y.; Kohsaka, S. Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J. Neurochem. 2004, 88, 844–856. [Google Scholar] [CrossRef] [PubMed]
  114. Ohsawa, K.; Imai, Y.; Kanazawa, H.; Sasaki, Y.; Kohsaka, S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell Sci. 2000, 113, 3073–3084. [Google Scholar] [CrossRef] [PubMed]
Cells 13 01528 g001
Figure 1. Study flow diagram, according to PRISMA extension for scoping reviews [18].
Figure 1. Study flow diagram, according to PRISMA extension for scoping reviews [18].
Cells 13 01528 g001
Cells 13 01528 g002
Figure 2. Schematic presentation of the main findings of this scoping review. ES, endolymphatic sac; OC, organ of Corti. Created with BioRender.com.
Figure 2. Schematic presentation of the main findings of this scoping review. ES, endolymphatic sac; OC, organ of Corti. Created with BioRender.com.
Cells 13 01528 g002
Cells 13 01528 g003
Figure 3. The location of macrophages, leukocytes, lymphocytes, and mast cells at a steady state in the human inner ear with emphasis on the cochlea. ST, scala tympani, SM, scala media, SV, scala vestibuli. Created with BioRender.com.
Figure 3. The location of macrophages, leukocytes, lymphocytes, and mast cells at a steady state in the human inner ear with emphasis on the cochlea. ST, scala tympani, SM, scala media, SV, scala vestibuli. Created with BioRender.com.
Cells 13 01528 g003
Table 1. Inclusion and exclusion criteria used to select manuscripts.
Table 1. Inclusion and exclusion criteria used to select manuscripts.
Inclusion CriteriaPeer-reviewed, full-text articles reporting original data;
Papers primarily or partially focused on immune cells within the inner ear;
Articles that primarily consider cochlear implants, sensorineural or noise-induced hearing loss were included only if a control group was represented;
Research performed on the mammalian inner ear.
Exclusion CriteriaConference abstracts, review papers, letters to the editor, opinion pieces, news, or case reports;
Not primarily concerned with the inner ear (e.g., middle ear);
Articles mainly dealing with systemic autoimmune diseases (e.g., granulomatosis with polyangiitis, spondylarthritis);
Lack of at least one of the following terms in their title/abstract or the keywords in combination with immune cells: cochlea, inner ear, endolymphatic duct, endolymphatic sac, the organ of Corti (OC), vestibular organ, vestibular system;
Articles were excluded when the study design used an intervention in the inner ear in the controls.
Table 2. Characteristics of the included studies (n = 49).
Table 2. Characteristics of the included studies (n = 49).
Number of Studies (% of All Studies Included)
Year of publication<19803 (6%)
1980–19852 (4%)
1985–19904 (8%)
1990–20003 (6%)
2000–20053 (6%)
2005–20107 (14%)
2010–20156 (12%)
2015–202019 (38%)
2020–20222 (4%)
ContinentEurope17 (34%)
Asia9 (18%)
North America23 (46%)
Method usedImmunohistochemistry16 (32%)
Immunofluorescence26 (53%)
Electron microscopy7 (14%)
Research profile of publishing groupOtorhinolaryngology32 (65%)
Pathology2 (4%)
Hearing research center9 (18%)
Multiple departments2 (4%)
Other4 (8%)
Table 6. Types and distribution of immune cells in the human inner ear.
Table 6. Types and distribution of immune cells in the human inner ear.
Number of Specimens AnalyzedIdentified Immune Cell(s)Antibodies Used for IdentificationImmune Cell DistributionQuantificationRefs.
60T cells (CD4 and CD8), B cells, Langerhans cells, IgA- or IgG-containing lymphoid cells, MacrophagesT cells: CD45, CD8, CD4, CD6, CD5, DAKO-UCHL-1, DAKO-T1; Langerhans cells: CD1; B cells: IgA, IgG, CD22; macrophages: anti-lysozymeT cells: epithelium, lumen, and stroma of ES; B cells: stroma and occasionally lumen of ES; Langerhans cells: occasionally epithelial layer of ES; IgA- or IgG-producing B cells: perisaccular area and lumen of ES macrophages; lumen and perisaccular stroma.-[65]
-Plasma cells with cytoplasmic IgA IgM, IgG, IgAPerisaccular region of ES.-[66]
-Macrophages, LymphocytesIBA1, CD68, CX3CL1, TLR4, CD11b, CD4, CD8a, MHCIIIBA1-positive macrophages: subepithelial tissue and epithelium of ES in the stria vascularis and spiral ganglion; spiral ligament.
TLR4-positive cells: among subepithelial cells in the intermediate ES.
CD4- and CD8-positive lymphocytes:
in the ES.		-[67]
6MacrophagesIBA1Lateral wall, including the spiral ligament, scala vestibule and scala tympani, spiral limbus, spiral lamina, spiral and vestibular ganglion; in the OC.-[68]
5Macrophages, LymphocytesIBA1, CD4, CD8, CD11b, CD68, MHCII, CX3CL1IBA1-positive macrophages: connective tissue and epithelium of the ES;
stria vascularis, around the blood vessels; spiral ligament, scala vestibuli and tympani; spiral limbus, spiral lamina. In the OC, surrounding spiral ganglion. CD4- and CD8-positive lymphocytes:
around modiolar blood vessels and along the border of Rosenthal’s canal; spiral ligament.		-[69]
5Macrophages, LymphocytesIBA1, MHCII, CX3CL1, CD11b, CD4, CD8αCD4- and CD8-positive lymphocytes around vessels of the modiolus and along the border of the Rosenthal’s canal; scala tympani, spiral ligament.
IBA1-positive macrophages: stria vascularis, among the neurons in
the Rosenthal’s canal, OC.		-[69]
5Macrophages, LymphocytesIBA1, MHCII, CX3CL1, CD11b, CD4, CD8αCD4- and CD8-positive lymphocytes: around vessels of the modiolus, spiral ligament. IBA1-positive macrophages: stria vascularis, among the neurons in the Rosenthal’s canal, in the modiolus.-[70]
5MacrophagesIBA1, CD163IBA1-positive macrophages: stria vascularis, in the osseous spiral lamina and Rosenthal’s canal.
CD163-positive macrophages: spiral ligament, osseous spiral lamina, and Rosenthal’s canal.		Apical turn: 2.7 ± 1.0; middle turn: 7.8 ± 3.5; basal turn 11.3 ± 6.5. Spiral ligament apical turn: 1.0 ± 1; middle turn: 4.0 ± 3.3; basal turn: 4.9 ± 3.0.[71]
5Macrophages, LymphocytesIBA1, CD11b, CD4, CD8a, TLR4, MHCIIIBA1-positive macrophages: subepithelial tissue, epithelium, perisaccular connective tissue, sac lumen; stria vascularis, spiral ganglion, spiral ligament; CD4- and CD8-positive lymphocytes: in the ES.-[72]
114MacrophagesCD163, CD68, Iba1CD68-, IBA1-, and CD163-positive macrophages: spiral ligament, along the basilar membrane on the perilymphatic compartment, within the tunnel of Corti, along Reissner’s membrane, in the osseous spiral lamina, along blood vessels, among the spiral ganglion cells, in the endolymphatic duct.-[63]
80MacrophagesIBA1Crista ampularis, neuroepithelium, subepithelial stroma, mid-stroma.-[61]
20MacrophagesIba1OC, under the basilar membrane, in the perilymphatic compartment, around the blood vessels; stria vascularis, osseous spiral lamina.-[62]
-Plasma cells, Monocytes, and/or Macrophages-Within the epithelium, around the ES.-[73]
10Monocytes, Macrophages,
Granulocytes, Leukocytes		Leu4, Leu3, Leu2, Bl, T29/33, OKMlMacrophages: lumen of the human ES. Monocytes: limited to the ES vasculature. Leukocytes: within the subepithelial space. Lymphocytes: within the subepithelial space.-[64]
-Macrophages, LeukocytesIBA1, CX3CL1, CX3CR1, P2Y12, MHCII, CD11b, CD117, CD19, CD8α, CD4, CD68, TLR4, TMEM119, vimentin, collagen type IVIBA1-positive macrophages: lateral cochlear wall, spiral limbus, Reissner’s membrane, osseous spiral lamina, surrounding blood vessels, the wall of the scala vestibuli and tympani, a few occasionally in the OC, around the spiral ganglion. Macrophages: spiral ligament among types II, IV, and V fibrocytes, spiral ganglion. CD4- and CD8-positive lymphocytes: modiolus around blood vessels.-[74]
2Macrophagesosmic acid- and iron–hematoxylin-stainedThe connective tissue of the planum semilunatum in the canalicular wall, surrounding a big vessel of the stria vascularis.-[67]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Karayay, B.; Olze, H.; Szczepek, A.J. Mammalian Inner Ear-Resident Immune Cells—A Scoping Review. Cells 2024, 13, 1528. https://doi.org/10.3390/cells13181528

AMA Style

Karayay B, Olze H, Szczepek AJ. Mammalian Inner Ear-Resident Immune Cells—A Scoping Review. Cells. 2024; 13(18):1528. https://doi.org/10.3390/cells13181528

Chicago/Turabian Style

Karayay, Betül, Heidi Olze, and Agnieszka J. Szczepek. 2024. "Mammalian Inner Ear-Resident Immune Cells—A Scoping Review" Cells 13, no. 18: 1528. https://doi.org/10.3390/cells13181528

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop